Literature DB >> 1185521

Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

J M Strong, J S Dutcher, W K Lee, A J Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1185521     DOI： 10.1007/bf01066919

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  15 in total

1.  The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethylaminoethanol.

Authors:  B B BRODIE; P A LIEF; R POET
Journal:  J Pharmacol Exp Ther       Date:  1948-12       Impact factor: 4.030

2.  Studies on the metabolism of para-aminobenzoic acid.

Authors:  C W TABOR; M V FREEMAN; J BAILY; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1951-06       Impact factor: 4.030

3.  Metabolic oxidation on aliphatic basic nitrogen atoms and their -carbon atoms--some unifying principles.

Authors:  A H Beckett; J M van Dyk; H H Chissick; J W Gorrod
Journal:  J Pharm Pharmacol       Date:  1971-10       Impact factor: 3.765

4.  Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

5.  N-acetylprocainamide: an active metabolite of procainamide.

Authors:  D E Drayer; M M Reidenberg; R W Sevy
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

6.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

7.  Metabolism of procainamide in rhesus monkey and man.

Authors:  J Dreyfuss; J T Bigger; A I Cohen; E C Schreiber
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

8.  Absorption, excretion, and biotransformation of procainamide-C 14 in the dog and rhesus monkey.

Authors:  J Dreyfuss; J J Ross; E C Schreiber
Journal:  Arzneimittelforschung       Date:  1971-07

9.  Acetylation of procaine amide in man. A preliminary communication.

Authors:  E Karlsson; G Aberg; P Collste; L Molin; B Norlander; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

10.  Antiarrhythmic potency of N-acetylprocainamide.

Authors:  J Elson; J M Strong; W K Lee; A J Atkinson
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875
View more
  19 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Metabolomics reveals the metabolic map of procainamide in humans and mice.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Bernhard Dick; Felix J Frey; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2012-02-24       Impact factor: 5.858

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 4.  Effect of active drug metabolites on plasma level-response correlations.

Authors:  A J Atkinson; J M Strong
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

5.  Serum procainamide levels as therapeutic guides.

Authors:  J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 6.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

7.  Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.

Authors:  J J Lima; D R Conti; A L Goldfarb; W J Tilstone; L H Golden; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

8.  Comparison of the acetylation of procainamide and sulfadimidine in man.

Authors:  K Frislid; M Berg; V Hansteen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

9.  Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.

Authors:  C Sonnhag; E Karlsson
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of procainamide.

Authors:  E Karlsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.